Assessing Toyo Suisan Kaisha (TSE:2875) Valuation After New 2026 Earnings Guidance and Dividend Confirmation

Toyo Suisan Kaisha (TSE:2875) just laid out fresh earnings guidance for the year ending March 2026, along with confirmation of its next dividend payout. These updates are putting the company in the investor spotlight this week.

See our latest analysis for Toyo Suisan Kaisha.

Toyo Suisan Kaisha’s recent updates have come amid steady momentum, with the stock advancing over 8% in the past 90 days. While this year’s share price return is slightly negative, investors have benefited from a solid 6% total shareholder return over the past 12 months. Long-term holders have seen the value of their position more than double in the last three years. Guidance and a confirmed dividend appear to be reinforcing confidence in the company’s ongoing performance.

If today’s earnings news has you thinking about broader market opportunities, now’s the perfect chance to discover fast growing stocks with high insider ownership

With shares still sitting at an almost 29% discount to intrinsic value and analysts expecting further upside, the question now is whether Toyo Suisan Kaisha is undervalued or if the market already reflects future growth prospects.

Price-to-Earnings of 16.4x: Is it justified?

Toyo Suisan Kaisha's shares currently trade at a price-to-earnings (P/E) ratio of 16.4x, signaling that the market may be undervaluing the company's earnings relative to its fair value and its peers.

The price-to-earnings ratio compares a company’s current share price against its per-share earnings. It is a widely used metric for companies in the food sector because it captures profitability and growth potential in a single figure. For Toyo Suisan Kaisha, a P/E of 16.4x reflects how much investors are willing to pay for each yen of earnings today.

With the stock valued below the estimated fair P/E ratio of 20x, there is a notable margin for price appreciation if the market recorrects. Additionally, compared to the peer average of 18.2x, Toyo Suisan Kaisha is trading at an attractive level, though it is slightly higher than the industry average of 16.1x. This suggests the market may not be fully appreciating either the company’s consistent growth or the quality of its earnings. The fair ratio points to the level where the stock’s valuation could rise if investor sentiment shifts to match fundamentals.

Explore the SWS fair ratio for Toyo Suisan Kaisha

Result: Price-to-Earnings of 16.4x (UNDERVALUED)

However, slower revenue or profit growth than expected could limit upside, and market sentiment may shift rapidly if industry conditions deteriorate.

Find out about the key risks to this Toyo Suisan Kaisha narrative.

Another View: What Does the SWS DCF Model Indicate?

Switching gears, our SWS DCF model currently estimates Toyo Suisan Kaisha’s fair value at ¥14,611, while shares trade at ¥10,425. This suggests the stock is valued almost 29% below where our calculations indicate it should be. Is the market overlooking long-term potential, or is this caution justified?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Toyo Suisan Kaisha for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 856 undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Build Your Own Toyo Suisan Kaisha Narrative

If you want to dig deeper or take a different perspective, you can quickly build your own analysis in just a few minutes. Do it your way

A good starting point is our analysis highlighting 4 key rewards investors are optimistic about regarding Toyo Suisan Kaisha.

Looking for More Smart Opportunities?

Don’t leave your next winning idea to chance. Unearth promising stocks across fast-moving sectors using these tailored lists from Simply Wall Street’s powerful screener tools.

• Spot companies unlocking the future of medicine by starting with these 32 healthcare AI stocks, a tool built to capture breakthroughs driving healthcare innovation.
• Secure steady income with these 15 dividend stocks with yields > 3% and see which stocks offer reliable yields greater than 3% in today's market.
• Jump ahead on the AI revolution by reviewing these 25 AI penny stocks, designed for investors seeking companies powering artificial intelligence growth.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com